EYE » Topics » 18 U.S.C. SECTION 1350

This excerpt taken from the EYE 10-K filed Feb 24, 2009.

18 U.S.C. SECTION 1350

The undersigned, James V. Mazzo and Michael J. Lambert, the Chief Executive Officer and the Principal Financial Officer, respectively, of Advanced Medical Optics, Inc. (the “Company”), pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, hereby certify to the best of their knowledge that:

(i) the Annual Report on Form 10-K of the Company for the annual period ended December 31, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 20, 2009

 

/s/ JAMES.V.MAZZO

James V. Mazzo,
Chairman of the Board and Chief Executive Officer

/s/ MICHAEL J. LAMBERT

Michael J. Lambert
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
This excerpt taken from the EYE 10-K filed Mar 3, 2008.

18 U.S.C. SECTION 1350

The undersigned, James V. Mazzo and Richard A. Meier, the Chief Executive Officer and the Principal Financial Officer, respectively, of Advanced Medical Optics, Inc. (the “Company”), pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, hereby certify to the best of their knowledge that:

(i) the Annual Report on Form 10-K of the Company for the annual period ended December 31, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 28, 2008

/s/  JAMES V. MAZZO                                        

James V. Mazzo,

Chairman of the Board and Chief Executive Officer

/s/  RICHARD A. MEIER                                    

Richard A. Meier,

President and Chief Operating Officer

(Principal Financial Officer)

This excerpt taken from the EYE 10-Q filed Apr 29, 2005.

18 U.S.C. SECTION 1350

 

The undersigned, James V. Mazzo and Richard A. Meier, the Chief Executive Officer and the Chief Financial Officer, respectively, of Advanced Medical Optics, Inc. (the “Company”), pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, hereby certify to the best of their knowledge that:

 

(i) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 25, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

 

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:     April 26,     2005

 

/S/ JAMES V. MAZZO

James V. Mazzo,

President and Chief Executive Officer

/S/ RICHARD A. MEIER

Richard A. Meier,

Executive Vice President of Operations and Finance, and Chief Financial Officer

 

RELATED TOPICS for EYE:

"18 U.S.C. SECTION 1350" elsewhere:

Orthovita (VITA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki